Abbott Sues To Block Generic Depakote, Again
Abbott Laboratories has moved again to forestall a generic version of its billion-dollar anti-seizure drug Depakote, lobbing a lawsuit at Sun Pharmaceutical Industries Ltd. that claims Sun's proposed generic medication infringes...To view the full article, register now.
Already a subscriber? Click here to view full article